Mast Cells and Anaphylaxis
- 作者:Phil Lieberman ; Lene Heise Garvey
- 关键词:Anaphylaxis ; Mast cell ; Basophil ; Immunoglobulin E ; Mast cell secretagogues ; MRGPRX2 ; Tryptase ; Mast cell mediators
- 刊名:Current Allergy and Asthma Reports
- 出版年:2016
- 出版时间:March 2016
- 年:2016
- 卷:16
- 期:3
- 全文大小:915 KB
- 参考文献:1.Allergy in theory and practice. In: RA Cooke, ed. W. B. Saunders Company, Philadelphia, 1947.
2.Avenberg KM, Harper DS, Larsson BL. Footnotes on allergy. Uppsala: Published by Pharmacia AB; 1980. p. 84–5.
3.Samter M. Excerpts from classics in allergy (edited for the 25th Anniversary Committee of the American Academy of Allergy, Asthma, and Immunology). Published by Ross Laboratories, Columbus; copyright 1969. Library of Congress Catalog Number 70-77908, 32–33.
4.Riley JF, West GB. Histamine in tissue mast cells. J Physiol. 1952;117(4):72P–3.PubMed
5.Mota I. Action of anaphylactic shock and anaphylatoxin on mast cells and histamine in rats. Brit J Pharmacol. 1957;12:453–7.PubMedCentral PubMed
6.Zayas E, da Silva M, Jamur MC, Oliver C. Mast cell function: a new vision of an old cell. J Histochem Cytochem. 2014;62(10):698–738. doi:10.1369/0022155414545334 .CrossRef
7.•
Maaninka K, Lappalainen J, Kovanen PT. Human
mast cells arise from a common circulating progenitor. J Allergy Clin Immunol. 2013;132(2):463–9. These investigators demonstrated conclusively that
mast cells that reside in the mucosal tissue (known as MC
mast cells) and
mast cells that reside in the connective tissue (known as MCTC
mast cells) have a common progenitor. They demonstrate that these
cells assume their phenotypic profiles only upon reaching the tissue in which they reside after exiting the bone marrow.
8.••
Theoharides TC, Valent P, Akin C. Mast
cells,
mastocytosis, and related disorders. N Engl J Med. 2015;373:163–72. doi:10.1056/NEJMra1409760 . A superb and comprehensive review on the role of
mast cells in the production of anaphylactic events with an emphasis on
mast cell activation disorders such as systemic
mastocytosis, urticaria pigmentosa, and other
mast cell activating syndromes.CrossRef PubMed
9.Bradding P, Feather IH, Wilson S, Bardin PG, Heusser CH, Holgate ST, et al. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The
mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation. J Immunol. 1993;151(7):3853–65.PubMed
10.Qu Z, Liebler JM, Powers MR, Galey T, Ahmadi P, Huang XN, et al. Mast
cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma. Am J Pathol. 1995;147(3):564.PubMedCentral PubMed
11.Gordon JR, Galli SJ. Mast
cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin. Nature. 1990;346(6281):274.CrossRef PubMed
12.Jaffe JS, Glaum MC, Raible DG, Post TJ, Dimitry E, Govindarao D, et al. Human lung
mast cell IL-5 gene and protein expression: temporal analysis of upregulation following IgE-mediated activation. Am J Respir Cell Mol Biol. 1995;13(6):665.CrossRef PubMed
13.Bradding P, Saito H. Biology of
mast cells and their mediators. In: Middleton’s Allergy: Principles and Practice, Ed 8, 228-251, 2014 (edited by N. Franklin Adkinson Jr., M.D., Bruce S. Bochner, M.D.).
14.Weidner N, Horan RF, Austen KF. Mast-
cell phenotype in indolent forms of
mastocytosis. Ultrastructural features, fluorescence detection of avidin binding, and immunofluorescent determination of chymase,
tryptase, and carboxypeptidase. Am J Pathol. 1992;140(4):847–57.PubMedCentral PubMed
15.Bradding P, Okayama Y, Howarth PH, Church MK, Holgate ST. Heterogeneity of human
mast cells based on cytokine content. J Immunol. 1995;155:297–307.PubMed
16.•
Saito H, Ishizaka T, Ishizaka K. Mast
s and IgE: from history to today. Allergol Int. 2013;62(1):3–12. doi:10.2332/allergolint.13-RAI-0537 . A comprehensive history of the relationship between IgE and the
with a detailed description of the necessity for a divalent antigen bridging to adjacent
17.Kishimoto TK, Viswanathan K, Ganguly T, Elankumaran S, Smith S, Pelzer K, et al. Contaminated heparin associated with adverse clinical events and activation of the contact system. N Engl J Med. 2008;358:2457–67.PubMedCentral CrossRef PubMed
18.Schwartz LB. Heparin comes clean. N Engl J Med. 2008;358:2505–9.CrossRef PubMed
19.Kaplan AP, Hunt KJ, Sobotka AK, et al. Human anaphylaxis: a study of mediator systems. Clin Rev. 1977;25:361.
20.Van der Linden PW, Hack CE, Kerckhaert J, et al. Preliminary report: complement activation in wasp-sting anaphylaxis. Lancet. 1990;336:904–6.CrossRef PubMed
21.Van Hagge-Hamsten M, Hack CE, Eerenberg AJ, et al. Contact system activation and angioedema in insect-sting anaphylaxis. J Allergy Clin Immunol. 1993;91:283.